Organotypic endothelial adhesion molecules are key for Trypanosoma brucei tropism and virulence.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
21 09 2021
Historique:
received: 02 04 2021
revised: 29 06 2021
accepted: 28 08 2021
entrez: 22 9 2021
pubmed: 23 9 2021
medline: 16 2 2022
Statut: ppublish

Résumé

Trypanosoma brucei is responsible for lethal diseases in humans and cattle in Sub-Saharan Africa. These extracellular parasites extravasate from the blood circulation into several tissues. The importance of the vasculature in tissue tropism is poorly understood. Using intravital imaging and bioluminescence, we observe that gonadal white adipose tissue and pancreas are the two main parasite reservoirs. We show that reservoir establishment happens before vascular permeability is compromised, suggesting that extravasation is an active mechanism. Blocking endothelial surface adhesion molecules (E-selectin, P-selectins, or ICAM2) significantly reduces extravascular parasite density in all organs and delays host lethality. Remarkably, blocking CD36 has a specific effect on adipose tissue tropism that is sufficient to delay lethality, suggesting that establishment of the adipose tissue reservoir is necessary for parasite virulence. This work demonstrates the importance of the vasculature in a T. brucei infection and identifies organ-specific adhesion molecules as key players for tissue tropism.

Identifiants

pubmed: 34551286
pii: S2211-1247(21)01194-3
doi: 10.1016/j.celrep.2021.109741
pmc: PMC8480282
pii:
doi:

Substances chimiques

Antibodies 0
Antigens, CD 0
CD36 Antigens 0
Cell Adhesion Molecules 0
E-Selectin 0
ICAM-2 protein, mouse 0
P-Selectin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109741

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Exp Parasitol. 2018 May;188:93-101
pubmed: 29627328
Cell Metab. 2018 Jan 9;27(1):252-262.e3
pubmed: 29320705
Compr Physiol. 2016 Mar 15;6(2):975-1003
pubmed: 27065172
Parasitol Res. 2017 Mar;116(3):827-838
pubmed: 28013375
Gerontology. 2012;58(1):15-23
pubmed: 21135534
Front Immunol. 2016 Nov 07;7:463
pubmed: 27872623
Front Immunol. 2020 Mar 11;11:382
pubmed: 32218784
Infect Genet Evol. 2018 Sep;63:391-403
pubmed: 29339220
J Exp Med. 2012 Jan 16;209(1):93-107
pubmed: 22184632
Infect Immun. 2005 Apr;73(4):1986-94
pubmed: 15784539
Nat Rev Microbiol. 2006 Nov;4(11):849-56
pubmed: 17041632
Parasitol Res. 2013 Dec;112(12):4177-83
pubmed: 24018709
Adv Parasitol. 2015 Apr;88:51-84
pubmed: 25911365
Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E945-64
pubmed: 24549398
Vet Pathol. 2013 Jan;50(1):7-22
pubmed: 23345459
Trends Parasitol. 2001 Nov;17(11):538-45
pubmed: 11872399
Nat Commun. 2016 May 26;7:11659
pubmed: 27225796
Nature. 1966 Oct 29;212(5061):469-72
pubmed: 5339140
Cell Microbiol. 2019 Dec;21(12):e13117
pubmed: 31512335
Cell Host Microbe. 2016 Jun 8;19(6):837-48
pubmed: 27237364
Cell Microbiol. 2019 May;21(5):e13023
pubmed: 30825872
Nat Rev Immunol. 2015 Nov;15(11):692-704
pubmed: 26471775
PLoS Pathog. 2010 Sep 30;6(9):e1001032
pubmed: 20941396
Front Cell Infect Microbiol. 2019 Apr 16;9:103
pubmed: 31041194
Cytometry A. 2010 Nov;77(11):1067-74
pubmed: 20872885
Open Biol. 2019 May 31;9(5):190036
pubmed: 31088251
Mol Imaging Biol. 2011 Dec;13(6):1114-23
pubmed: 20960234
J Clin Pathol. 2001 Jan;54(1):1-3
pubmed: 11271782
Front Immunol. 2019 Nov 22;10:2738
pubmed: 31824512
Infect Immun. 2008 Sep;76(9):3924-31
pubmed: 18559428
J Appl Physiol. 1966 Jan;21(1):81-7
pubmed: 5903948
Cell Microbiol. 2011 Jan;13(1):109-22
pubmed: 20923452
Prog Neurobiol. 2010 Jun;91(2):152-71
pubmed: 19995590
Nat Rev Microbiol. 2020 Mar;18(3):177-189
pubmed: 31919479
Elife. 2016 Oct 14;5:
pubmed: 27740910
Cell Microbiol. 2019 May;21(5):e13024
pubmed: 30830993
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1572-9
pubmed: 18723769
Physiol Rev. 2019 Jul 1;99(3):1467-1525
pubmed: 31140373
Sci Rep. 2013;3:1932
pubmed: 23732999
Trends Parasitol. 2005 Feb;21(2):75-80
pubmed: 15664530
Cell Host Microbe. 2020 Oct 7;28(4):509-515
pubmed: 33031769
Sci Rep. 2018 Jul 11;8(1):10456
pubmed: 29993021
Mediators Inflamm. 2015;2015:946509
pubmed: 26568666
Rev Hosp Clin Fac Med Sao Paulo. 2002 Mar-Apr;57(2):63-6
pubmed: 11981586
Am J Trop Med Hyg. 1980 Nov;29(6):1138-42
pubmed: 7446805
Elife. 2016 Sep 22;5:
pubmed: 27653219
Elife. 2015 Aug 13;4:
pubmed: 26271010
Cell Microbiol. 2004 Apr;6(4):303-17
pubmed: 15009023
J R Soc Interface. 2009 Jun 6;6(35):519-28
pubmed: 19033138
Science. 2017 Aug 25;357(6353):
pubmed: 28775214
J Immunol. 1999 Jan 15;162(2):1137-43
pubmed: 9916744
PLoS Pathog. 2014 Apr 17;10(4):e1004014
pubmed: 24743351
FEMS Microbiol Rev. 2012 May;36(3):734-47
pubmed: 22339763
Micromachines (Basel). 2018 Feb 02;9(2):
pubmed: 30393339
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Family Med Prim Care. 2016 Jul-Sep;5(3):691-694
pubmed: 28217609
Lab Invest. 2002 May;82(5):521-33
pubmed: 12003992
Cell Microbiol. 2020 Jun;22(6):e13201
pubmed: 32149435

Auteurs

Mariana De Niz (M)

Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa 1649-028, Portugal.

Daniela Brás (D)

Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa 1649-028, Portugal.

Marie Ouarné (M)

Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa 1649-028, Portugal.

Mafalda Pedro (M)

Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa 1649-028, Portugal; Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica 2825-149, Portugal.

Ana M Nascimento (AM)

Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa 1649-028, Portugal; Bioimaging Unit, Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa 1649-028, Portugal.

Lenka Henao Misikova (L)

Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa 1649-028, Portugal.

Claudio A Franco (CA)

Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa 1649-028, Portugal.

Luisa M Figueiredo (LM)

Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa 1649-028, Portugal. Electronic address: lmf@medicina.ulisboa.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH